CHICAGO, Nov. 14, 2016
/PRNewswire/ -- DaVita Clinical Research, a specialty contract
research organization with services spanning the full spectrum of
drug and device development, today announced that company
representatives and collaborators will present 12 abstracts at
American Society of Nephrology (ASN) Kidney Week in Chicago, Nov.
15-20. Attendees can meet representatives of DaVita Clinical
Research and DaVita Kidney Care, the kidney care division of DaVita
Inc. (NYSE: DVA), in booth 710.
ASN's annual Kidney Week is the world's premier nephrology
meeting, bringing together more than 13,000 kidney care
professionals from around the world to share and discuss new
developments related to all aspects of nephrology. This year's
meeting theme is "Reinventing Nephrology: From Molecule to Man" and
also celebrates ASN's 50th Anniversary.
"DaVita Clinical Research and DaVita
Kidney Care are committed to improving clinical outcomes in
patients with kidney disease. We invest in quality initiatives and
research that improve our understanding of disease prevention and
treatment," said Steven Brunelli,
MD, MSCE, vice president of DaVita Clinical Research.
Researchers from DaVita Clinical Research and DaVita Kidney Care will present results from a
number of large retrospective studies. The group also will present
data from innovative clinical improvement programs originating from
DaVita Clinical Research and its independent research partners in
the academic, pharmaceutical and biotech research communities.
DaVita Clinical Research and DaVita
Kidney Care representatives will share the results from the
following clinical quality initiatives during the conference's
poster sessions.
- "In-Center Hemodialysis Absenteeism: Prevalence and Association
with Outcomes." Poster presentation by Steven M. Brunelli, MD, MSCE, on Thursday, Nov. 17 between
10 a.m. and 12 p.m., poster TH-PO1060.
- "Implementation of a Motivational Interviewing Program to
Improve Patient Engagement within a Large Dialysis Organization."
Poster presentation by Deborah Benner, MA, RD, CSR, on Thursday, Nov. 17 between 10 a.m. and 12 p.m., poster TH-PO760.
- "The Impact of Gender on Prescription and Use of Vascular
Access in Elderly Patients on Hemodialysis: A European Hemodialysis
Multicenter Analysis." Poster presentation by Andre Weigert, MD, on Thursday, Nov. 17 between 10 a.m. and
12 p.m., poster TH-PO1030.
- "Obesity Paradox in Hemodialysis: Could Omega 3 Be the Link?"
Poster presentation by Ana Rita
Martins, MD, PhD, on Thursday, Nov.
17 between 10 a.m. and 12 p.m., poster
TH-PO740.
- "Standardized Dialysate Temperature of 36 Degrees Celsius:
Association with Clinical Outcomes." Poster presentation by
Kathryn Gray, MS, on Friday, Nov. 18 between 10
a.m. and 12 p.m., poster FR-PO939.
- "Higher End-Stage Renal Disease (ESRD) Star Ratings Are
Associated with Lower Mortality, Hospitalization and Readmission
Ratios." Poster presentation by Andrea
Besharat, MPH, on Friday, Nov.
18 between 10 a.m. and 12
p.m., poster FR-PO944.
- "Nasal Methicillin-Resistant Staphylococcus Aureus Carriage in
Hemodialysis Patients: Hospital-Based Versus Separate Dialysis
Centers." Poster presentation by Werner Kleophas, MD, on
Friday, Nov. 18 between 10 a.m. and 12 p.m., poster
FR-PO995.
- "Employment and Transplant Status among End-Stage Renal Disease
Patients Receiving Dialysis." Poster presentation by Deborah Evans,
MA, LCSW, on Saturday, Nov. 19 between
10 a.m. and 12 p.m., poster SA-PO370.
- "Achievement of Renal Anemia KDIGO Targets by Two Different
Strategies - A European Hemodialysis Multicenter Analysis." Poster
presentation by Maciej Drozdz, MD,
PhD on Saturday, Nov. 19 between 10 a.m. and 12 p.m., poster
SA-PO1023.
In addition, findings from the following research studies will
be presented.
- "Phosphorus Control and Pill Burden among In-Center
Hemodialysis and Peritoneal Dialysis Patients Converting to
Sucroferric Oxyhydroxide." Poster presentation by Kathryn Gray, MS, on Friday, Nov. 18 between 10
a.m. and 12 p.m., poster FR-PO424
- "Serum Potassium and Clinical Outcomes among Hemodialysis
Patients: Impact of the Long Interdialytic Interval." Poster
presentation by Steven M. Brunelli,
MD, MSCE, on Friday, Nov. 18
between 10 a.m. and 12 p.m., poster
FR-PO974.
- "Optimal Outcomes with Targeted Chronic Kidney Disease
Management." Oral presentation by Todd
Prewitt, MD, on Friday, Nov.
18 at 4.54 p.m., presentation
FR-OR077 in the "Patient-Centered Outcomes with Maintenance
Dialysis" oral abstract session to be held in room W185.
Attendees who visit DaVita Kidney
Care's booth at ASN will hear from clinical leaders in
nephrology, including DaVita Kidney
Care Chief Medical Officer Allen
Nissenson, MD, FACP, FASN; Chief Medical Officer for
DaVita Kidney Care in Saudi Arabia Abdulkareem Alsuwaida, MD, FRCPC,
MSc; Vice President of Clinical Affairs for Home Dialysis Martin
Schreiber, MD; Vice President of Medical Affairs Robert Provenzano, MD, FACP, FASN; Vice
President of Clinical Integrated Care Management Services Stephen
McMurray, MD, FASN; and Chief Medical Director for DaVita Kidney Care in EMEA Maciej Drożdż, MD,
PhD.
DaVita Kidney Care's ASN booth
schedule can be found online at DaVita.com/Physicians/ASN.
Attendees are encouraged to follow along with the conversation on
Twitter via hashtag #KidneyWk.
About DaVita Clinical Research
DaVita Clinical
Research (DCR), a wholly owned subsidiary of DaVita Inc.,
uses its extensive, applied database and real-world healthcare
experience to assist pharmaceutical and medical device companies in
the design, recruitment and completion of retrospective,
prospective and pragmatic clinical trials. DCR's scientific
and clinical expertise spans the lifecycle of product development
with more than 175 client companies. DCR's Early Clinical
Research unit (Phase I-IIa) and Late Phase Clinical
Research (Phase IIb through post-marketing) network of
physicians and investigative sites, Real-World Healthcare Data
and Medical Communications are focused on providing
world-class research in both complex/specialty populations and
therapeutic areas and especially in CKD and ESRD populations. To
learn more about DCR,
visit www.davitaclinicalresearch.com.
About DaVita Inc.
DaVita Inc., a Fortune 500® company,
is the parent company of DaVita Kidney
Care and HealthCare Partners, a DaVita Medical Group.
DaVita Kidney Care is a leading
provider of kidney care in the United
States, delivering dialysis services to patients with
chronic kidney failure and end stage renal disease. As of
September 30, 2016, DaVita Kidney Care operated or provided
administrative services at 2,318 outpatient dialysis centers
located in the United States
serving approximately 186,000 patients. The company also operated
139 outpatient dialysis centers located in 11 countries outside
the United States. HealthCare
Partners manages and operates medical groups and affiliated
physician networks in California,
Nevada, New Mexico, Florida, Colorado and Washington in its pursuit to deliver
excellent-quality health care in a dignified and compassionate
manner. As of September 30, 2016
HealthCare Partners provided integrated care management for
approximately 750,000 patients. For more information, please visit
DaVita.com/about.
DaVita Kidney Care, DaVita
Clinical Research and DCR are trademarks or registered trademarks
of DaVita Inc. All other trademarks are the property of their
respective owners.
Contact Information
Media:
Kate Wilson Stabrawa
DaVita Clinical Research Media Relations
Office: (303) 876-7527
Kate.Stabrawa@DaVita.com
Logo - http://photos.prnewswire.com/prnh/20160822/400295LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/davita-clinical-research-to-present-12-abstracts-at-american-society-of-nephrology-kidney-week-2016-300362260.html
SOURCE DaVita Inc.